World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
79
Citations
16760
World Ranking
17762
National Ranking
343

Overview

Göran Landberg is affiliated with the University of Gothenburg in Sweden, focusing on the interdisciplinary fields of medicine, biochemistry, genetics, and molecular biology. Their research encompasses a range of subfields including oncology, molecular biology, biomedical engineering, cancer research, and surgery.

The scientist's work prominently explores various topics such as cancer cells and metastasis, 3D printing applications in biomedical research, tissue engineering and regenerative medicine, colorectal cancer treatments and studies, epigenetics and DNA methylation, advanced proteomics techniques, and amyotrophic lateral sclerosis research.

Frequent publication venues for their research include the Journal of Translational Medicine, Cancer Research, Cancer Medicine, Cancers, and the SSRN Electronic Journal. These journals reflect a consistent contribution to cancer biology and translational medicine.

Notable recent papers authored or co-authored by Göran Landberg include:

  • "Breast cancer patient-derived scaffolds as a tool to monitor chemotherapy responses in human tumor microenvironments" (2020, Journal of Cellular Physiology)
  • "The mevalonate precursor enzyme HMGCS1 is a novel marker and key mediator of cancer stem cell enrichment in luminal and basal models of breast cancer" (2020, PLoS ONE)
  • "Patient-derived scaffolds as a drug-testing platform for endocrine therapies in breast cancer" (2021, Scientific Reports)
  • "Breast cancer stromal clotting activation (Tissue Factor and thrombin): A pre-invasive phenomena that is prognostic in invasion" (2020, Cancer Medicine)
  • "Patient-derived scaffolds as a model of colorectal cancer" (2020, Cancer Medicine)

Collaborative efforts are evident with frequent co-authors including Anders Ståhlberg, Anna Gustafsson, Elena Garré, Joakim Håkansson, and Simona Salerno. These collaborations indicate a networked approach spanning molecular and clinical cancer research.

Best Publications

  • Hypoxia-induced dedifferentiation of tumor cells--a mechanism behind heterogeneity and aggressiveness of solid tumors.

    Håkan Axelson;Erik Fredlund;Marie Ovenberger;Göran Landberg

  • Prognostic significance of stromal platelet-derived growth factor beta-receptor expression in human breast cancer.

    Janna Paulsson;Tobias Sjöblom;Patrick Micke;Fredrik Pontén

  • Isolation and characterization of progenitor-like cells from human renal proximal tubules.

    David Lindgren;Anna Karin Boström;Kristina Nilsson;Jennifer Hansson

  • Flow cytometric multiparameter analysis of proliferating cell nuclear antigen/cyclin and Ki-67 antigen: A new view of the cell cycle

    Göran Landberg;Eng M. Tan;Göran Roos;Göran Roos

  • Cyclin E overexpression, a negative prognostic factor in breast cancer with strong correlation to oestrogen receptor status

    NH Nielsen;C Arnerlöv;SO Emdin;G Landberg

  • Hypoxia promotes a dedifferentiated phenotype in ductal breast carcinoma in situ.

    Karolina Helczynska;Åsa Kronblad;Annika Jögi;Elise Nilsson

  • Association between Pak1 expression and subcellular localization and tamoxifen resistance in breast cancer patients.

    Caroline Holm;Suresh Rayala;Karin Jirström;Olle Stål

  • Expression of the leukotriene D4 receptor CysLT1, COX-2, and other cell survival factors in colorectal adenocarcinomas.

    John F. Öhd;Christian Kamp Nielsen;Joan Campbell;Göran Landberg

  • Expression of vascular endothelial growth factor protein in human renal cell carcinoma

    Jan Jacobsen;Kjell Grankvist;Torgny Rasmuson;Anders Bergh

  • Targeting CXCR1/2 Significantly Reduces Breast Cancer Stem Cell Activity and Increases the Efficacy of Inhibiting HER2 via HER2-dependent and -independent Mechanisms

    Jagdeep K Singh;Gillian Farnie;Nigel J Bundred;Bruno M Simões

  • Cyclin D1 overexpression is a negative predictive factor for tamoxifen response in postmenopausal breast cancer patients.

    Maria Stendahl;Åsa Kronblad;Lisa Rydén;S Emdin

  • Hypoxia, Snail and incomplete epithelial–mesenchymal transition in breast cancer

    Katja Lundgren;B Nordenskjöld;Göran Landberg;Göran Landberg

  • Expression of Cyclin E and the Cyclin-Dependent Kinase Inhibitor p27 in Malignant Lymphomas—Prognostic Implications

    Martin Erlanson;Cajsa Portin;Barbro Linderholm;Jack Lindh

  • Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein

    Niels H. Nielsen;Stefan O. Emdin;Jenny Cajander;Göran Landberg

  • Antibodies to Proliferating Cell Nuclear Antigen as S-Phase Probes in Flow Cytometric Cell Cycle Analysis

    Göran Landberg;Göran Roos

  • Cell Cycle and Cell Size Dependent Gene Expression Reveals Distinct Subpopulations at Single-Cell Level.

    Soheila Dolatabadi;Julián Candia;Julián Candia;Nina Akrap;Christoffer Vannas

  • Anti-estrogen Resistance in Human Breast Tumors Is Driven by JAG1-NOTCH4-Dependent Cancer Stem Cell Activity.

    Bruno M. Simões;Ciara S. O'Brien;Rachel Eyre;Andreia Silva

  • High Progesterone Receptor Expression Correlates to the Effect of Adjuvant Tamoxifen in Premenopausal Breast Cancer Patients

    Maria Stendahl;Lisa Rydén;Bo Nordenskjöld;Per Ebbe Jönsson

  • Hypoxia and breast cancer: prognostic and therapeutic implications.

    K. Lundgren;C. Holm;G. Landberg

  • Expression of the cytoskeleton linker protein ezrin in human cancers

    Benjamin Bruce;Gaurav Khanna;Gaurav Khanna;Ling Ren;Goran Landberg

Frequent Co-Authors

Karin Jirström
Karin Jirström Lund University
Anders Ståhlberg
Anders Ståhlberg Sahlgrenska University Hospital
Jonas Manjer
Jonas Manjer Lund University
Robert Clarke
Robert Clarke University of Oxford
Börje Ljungberg
Börje Ljungberg Umeå University
Jonas Bergh
Jonas Bergh Karolinska Institute
Michael J. Duffy
Michael J. Duffy University College Dublin
Robert C. Millikan
Robert C. Millikan University of North Carolina at Chapel Hill
Robert E. Coleman
Robert E. Coleman University of Sheffield
John C. Morris
John C. Morris Washington University in St. Louis

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA often means navigating a wide range of degree pathways, especially with the growth of online education. If you're considering nursing as a career or advancement option, there are several flexible and affordable programs to consider.

For those already holding an RN license, pursuing cheap rn to bsn programs allows you to boost your qualifications and access more opportunities without incurring significant debt. Individuals who want to fast-track their transition into advanced nursing roles, even without a prior nursing background, can benefit from direct entry msn programs online.

If your goal is an academic or leadership role, many universities now offer online phd nursing options designed for working professionals. Additionally, for students seeking accessible admission processes, there are easiest nursing programs to get into that provide a less competitive entry point.

These diverse online degree pathways help prospective students launch or accelerate their medical careers, offering flexibility, affordability, and a range of specialization options.

Best Scientists Citing Göran Landberg

Trending Scientists